Send Inquiry

Request To Call Back

Paclitaxel Injection IP Pacliwin 30

Name: Paclitaxel Injection IP Pacliwin 30
Brand: PHP Lifesciences LLP
Price: 234 INR
Availability: InStock

Price 234 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Paclitaxel Injection IP Pacliwin 30 Specification

Salt Composition
Paclitaxel IP 30 mg

Dosage Form
Injection

Indication
Used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposis sarcoma.

Feature
Ready-to-use injectable anti-cancer medication

Application

Ph Level
3.0 - 4.0

Physical Color/Texture
Clear, colorless to pale yellow solution

Storage Instructions
Store below 25C. Do not freeze. Protect from light.

Shelf Life
24 months

Container Type
Glass Vial

Compatibility
Compatible with standard infusion fluids (0.9% Sodium Chloride, 5% Dextrose)

Dilution Required
Must be diluted prior to infusion

USP Standard
Meets IP Specifications

Route of Administration
Intravenous Infusion

Pack Size
30 mg/5 ml vial

Prescription Status
Prescription Only

Visual Inspection
Inspect visually for particulate matter and discoloration prior to administration

Paclitaxel Injection IP Pacliwin 30 Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Paclitaxel Injection IP Pacliwin 30

Spotlight your oncology therapy with Paclitaxel Injection IP Pacliwin 30. Buy the elite choice trusted by healthcare professionals in India and abroad for its proven efficacy in cancer treatment. Each dominant 30 mg/5 ml glass vial, ready for intravenous infusion, meets rigorous IP standards and primes clinicians for reliable care. Find safety through superior formulation: must be diluted before use, visually inspected, and stored below 25C. Designed for convenience, this prescription-only solution supports dealers, distributors, exporters, suppliers, and wholesalers seeking a premier product for antineoplastic therapy.

Paclitaxel Injection IP Pacliwin 30: Usage and Directions

Paclitaxel Injection IP Pacliwin 30 is specifically used for patients diagnosed with ovarian, breast, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma. To ensure safety, it must be diluted before intravenous infusion and inspected for clarity and color. The primary competitive advantage lies in its precision formulation, meeting IP specifications, which makes it a general and reliable choice for oncologists. Follow your clinician's direction strictly for optimal outcomes.

Paclitaxel Injection IP Pacliwin 30: Packaging Details and Export Markets

Pacliwin 30 is delivered in a secure glass vial, maintaining its value and integrity through robust packaging that meets market expectations. Market value increases as it is regularly charged to main export markets across Asia, Africa, and Europe via established FOB ports in India. This ready-to-use solution is available through leading traders, wholesalers, and distributors for international and domestic supply chains.

FAQ's of Paclitaxel Injection IP Pacliwin 30:

Q: How should Paclitaxel Injection IP Pacliwin 30 be prepared and administered?

A: Paclitaxel Injection IP Pacliwin 30 must be diluted with compatible infusion fluids such as 0.9% sodium chloride or 5% dextrose before intravenous infusion. Healthcare professionals should follow strict preparation guidelines and visually inspect the solution before administering.

Q: What types of cancer is Paclitaxel Injection IP Pacliwin 30 indicated for?

A: It is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma, making it an important chemotherapy option in oncology.

Q: When should Paclitaxel Injection IP Pacliwin 30 not be used?

A: It should not be used without prescription and preparation by a healthcare provider, and should not be administered if visual inspection reveals particulate matter or discoloration.

Q: Where can I buy Paclitaxel Injection IP Pacliwin 30 in India?

A: Paclitaxel Injection IP Pacliwin 30 can be obtained through authorized dealers, distributors, suppliers, and wholesalers who handle prescription oncology medications across India.

Q: What are the storage requirements for Paclitaxel Injection IP Pacliwin 30?

A: Store the product below 25C, protect it from light, and do not freeze to maintain optimum quality and efficacy throughout its 24-month shelf life.

Q: How does Paclitaxel Injection IP Pacliwin 30 offer competitive advantages?

A: Pacliwin 30 is valued for its ready-to-use formulation, compliance with IP standards, safe packaging, and robust supply chain support, making it a prime option for trade and clinical use.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Oncology Medicine Category

Cytarabine Injection BP Cyterawin 1000

Price 318 INR / Vial

Minimum Order Quantity : 10 Vials

Feature : Other, Sterile, readytouse, singledose or multidose vial

Application : Other, Anticancer, chemotherapy treatment

Storage Instructions : Store at 2C to 8C, protect from light. Do not freeze.

Indication : Used for treatment of certain leukemias such as acute myeloid leukemia, acute lymphocytic leukemia, and chronic myelogenous leukemia in blast crisis.

Get a Price/Quote

Cytarabine Injection BP Cyterawin 500

Price 252 INR / Vial

Minimum Order Quantity : 10 Vials

Feature : Other, Sterile, pyrogenfree, readytouse injection

Application : Other, Cytotoxic Chemotherapy

Storage Instructions : Store below 25C. Protect from light. Do not freeze.

Indication : Used in the treatment of certain cancers such as acute myeloid leukaemia (AML), acute lymphocytic leukaemia (ALL), and chronic myeloid leukaemia (CML)

Get a Price/Quote